These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20083493)

  • 1. Anti-glycophorin single-chain Fv fusion to low-affinity mutant erythropoietin improves red blood cell-lineage specificity.
    Taylor ND; Way JC; Silver PA; Cironi P
    Protein Eng Des Sel; 2010 Apr; 23(4):251-60. PubMed ID: 20083493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence in vitro of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umbilical cord blood and adult bone marrow.
    Lu L; Xiao M; Li ZH; Jolliffe LK; Jones S; Broxmeyer HE; Weich N
    Exp Hematol; 1995 Sep; 23(10):1130-4. PubMed ID: 7656932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-3/erythropoietin fusion proteins: in vitro effects on hematopoietic cells.
    Weich NS; Tullai J; Guido E; McMahon M; Jolliffe LK; Lopez AF; Vadas MA; Lowry PA; Quesenberry PJ; Rosen J
    Exp Hematol; 1993 May; 21(5):647-55. PubMed ID: 8513865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of Fc-erythropoietin structure and pharmacokinetics by modification at a disulfide bond.
    Way JC; Lauder S; Brunkhorst B; Kong SM; Qi A; Webster G; Campbell I; McKenzie S; Lan Y; Marelli B; Nguyen LA; Degon S; Lo KM; Gillies SD
    Protein Eng Des Sel; 2005 Mar; 18(3):111-8. PubMed ID: 15820978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
    Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
    EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of PEGylation and refolding for renaturation of recombinant proteins from insoluble aggregates produced in bacteria--application to a single-chain Fv fragment.
    Kumagai I; Asano R; Nakanishi T; Hashikami K; Tanaka S; Badran A; Sanada H; Umetsu M
    J Biosci Bioeng; 2010 May; 109(5):447-52. PubMed ID: 20347766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted erythropoietin selectively stimulates red blood cell expansion in vivo.
    Burrill DR; Vernet A; Collins JJ; Silver PA; Way JC
    Proc Natl Acad Sci U S A; 2016 May; 113(19):5245-50. PubMed ID: 27114509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lineage-restricted recruitment of immature hematopoietic progenitor cells in response to Epo after normal hematopoietic cell transfection with EpoR.
    McArthur GA; Longmore GD; Klingler K; Johnson GR
    Exp Hematol; 1995 Jul; 23(7):645-54. PubMed ID: 7601257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational Design of a Bifunctional AND-Gate Ligand To Modulate Cell-Cell Interactions.
    Lee J; Vernet A; Redfield K; Lu S; Ghiran IC; Way JC; Silver PA
    ACS Synth Biol; 2020 Feb; 9(2):191-197. PubMed ID: 31834794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of AcGFP fusion with single-chain Fv selected from a phage display library constructed from mice hyperimmunized against 5-methyl 2'-deoxycytidine.
    Ohshima M; Inoue K; Hayashi H; Tsuji D; Mizugaki M; Itoh K
    Protein Eng Des Sel; 2010 Nov; 23(11):881-8. PubMed ID: 20876190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient eukaryotic expression of fluorescent scFv fusion proteins directed against CD antigens for FACS applications.
    Peipp M; Saul D; Barbin K; Bruenke J; Zunino SJ; Niederweis M; Fey GH
    J Immunol Methods; 2004 Feb; 285(2):265-80. PubMed ID: 14980440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insertion of an NPVY sequence into the cytosolic domain of the erythropoietin receptor selectively affects erythropoietin-mediated signalling and function.
    Liron T; Nahari T; Souroujon MC; Neumann D
    Biochem J; 2010 Mar; 427(2):305-12. PubMed ID: 20136632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A diversity of antibody epitopes can induce signaling through the erythropoietin receptor.
    Lim AC; Ketchem RR; Borges L; Carabeo T; Carter J; Hoover JE; Hu Z; Wittekind M; Zhou H; Mehlin C
    Biochemistry; 2010 May; 49(18):3797-804. PubMed ID: 20337434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-engineering erythropoietin as an IgG fusion protein that penetrates the blood-brain barrier in the mouse.
    Zhou QH; Boado RJ; Lu JZ; Hui EK; Pardridge WM
    Mol Pharm; 2010 Dec; 7(6):2148-55. PubMed ID: 20860349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anti-TNFR1 scFv-HSA fusion protein as selective antagonist of TNF action.
    Berger V; Richter F; Zettlitz K; Unverdorben F; Scheurich P; Herrmann A; Pfizenmaier K; Kontermann RE
    Protein Eng Des Sel; 2013 Oct; 26(10):581-7. PubMed ID: 24006371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VH/VL interface engineering to promote selective expression and inhibit conformational isomerization of thrombopoietin receptor agonist single-chain diabody.
    Igawa T; Tsunoda H; Kikuchi Y; Yoshida M; Tanaka M; Koga A; Sekimori Y; Orita T; Aso Y; Hattori K; Tsuchiya M
    Protein Eng Des Sel; 2010 Aug; 23(8):667-77. PubMed ID: 20576629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
    Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
    Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.